News stories about Calyxt (NASDAQ:CLXT) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Calyxt earned a daily sentiment score of 0.13 on Accern’s scale. Accern also assigned news stories about the company an impact score of 46.7221614128348 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Shares of Calyxt (NASDAQ:CLXT) opened at $22.84 on Thursday. Calyxt has a fifty-two week low of $9.26 and a fifty-two week high of $31.89. The company has a current ratio of 12.41, a quick ratio of 12.41 and a debt-to-equity ratio of 0.13. The stock has a market cap of $634.45 and a price-to-earnings ratio of -25.10.

A number of research firms have recently issued reports on CLXT. Citigroup dropped their price objective on shares of Calyxt from $27.00 to $22.00 and set a “neutral” rating for the company in a report on Thursday, November 16th. Ladenburg Thalmann Financial Services began coverage on shares of Calyxt in a report on Wednesday, December 20th. They set a “buy” rating and a $34.25 price objective for the company. Wells Fargo & Co lifted their price objective on shares of Calyxt from $17.00 to $30.00 and gave the stock an “outperform” rating in a report on Friday, September 29th. Jefferies Group lifted their price objective on shares of Calyxt to $27.00 and gave the stock a “buy” rating in a report on Wednesday, November 1st. Finally, Zacks Investment Research downgraded shares of Calyxt from a “hold” rating to a “sell” rating in a report on Monday, October 16th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Calyxt currently has a consensus rating of “Buy” and an average price target of $29.05.

ILLEGAL ACTIVITY NOTICE: “Somewhat Positive Media Coverage Somewhat Unlikely to Affect Calyxt (CLXT) Share Price” was reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://theolympiareport.com/2017/12/28/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-calyxt-clxt-share-price.html.

Calyxt Company Profile

Calyxt, Inc is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics.

Insider Buying and Selling by Quarter for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.